0 XP   0   0   0

AARTI DRUGS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell AARTI DRUGS LTD.?

I guess you are interested in AARTI DRUGS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse AARTI DRUGS LTD.

Let's start. I'm going to help you getting a better view of AARTI DRUGS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is AARTI DRUGS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how AARTI DRUGS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value AARTI DRUGS LTD.. The closing price on 2023-01-27 was INR410.55 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
AARTI DRUGS LTD. Daily Candlestick Chart
AARTI DRUGS LTD. Daily Candlestick Chart
Summary









1. Valuation of AARTI DRUGS LTD.




Current price per share

INR410.55

2. Growth of AARTI DRUGS LTD.




Is AARTI DRUGS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$127.4m$112.3m$15.1m11.9%

How much money is AARTI DRUGS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$25.2m$34.4m-$9.2m-36.8%
Net Profit Margin8.2%13.0%--

How much money comes from the company's main activities?

3. Financial Health of AARTI DRUGS LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of AARTI DRUGS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit AARTI DRUGS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare AARTI DRUGS LTD. to the  industry mean.
  • A Net Profit Margin of 8.2% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AARTI DRUGS LTD.:

  • The MRQ is 8.2%. The company is making a profit. +1
  • The TTM is 8.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.2%TTM8.2%0.0%
TTM8.2%YOY13.0%-4.8%
TTM8.2%5Y8.7%-0.5%
5Y8.7%10Y8.7%0.0%
1.1.2. Return on Assets

Shows how efficient AARTI DRUGS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AARTI DRUGS LTD. to the  industry mean.
  • 9.3% Return on Assets means that AARTI DRUGS LTD. generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AARTI DRUGS LTD.:

  • The MRQ is 9.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM9.3%0.0%
TTM9.3%YOY15.9%-6.6%
TTM9.3%5Y10.1%-0.8%
5Y10.1%10Y10.1%0.0%
1.1.3. Return on Equity

Shows how efficient AARTI DRUGS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AARTI DRUGS LTD. to the  industry mean.
  • 19.8% Return on Equity means AARTI DRUGS LTD. generated ₹0.20 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AARTI DRUGS LTD.:

  • The MRQ is 19.8%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 19.8%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.8%TTM19.8%0.0%
TTM19.8%YOY30.7%-10.9%
TTM19.8%5Y22.2%-2.4%
5Y22.2%10Y22.2%0.0%

1.2. Operating Efficiency of AARTI DRUGS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient AARTI DRUGS LTD. is operating .

  • Measures how much profit AARTI DRUGS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AARTI DRUGS LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AARTI DRUGS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.6%-5.6%
5Y5.6%10Y5.6%0.0%
1.2.2. Operating Ratio

Measures how efficient AARTI DRUGS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are ₹1.68 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of AARTI DRUGS LTD.:

  • The MRQ is 1.678. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.678. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.678TTM1.6780.000
TTM1.678YOY1.538+0.140
TTM1.6785Y1.640+0.038
5Y1.64010Y1.6400.000

1.3. Liquidity of AARTI DRUGS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if AARTI DRUGS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.48 means the company has ₹1.48 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of AARTI DRUGS LTD.:

  • The MRQ is 1.482. The company is just able to pay all its short-term debts.
  • The TTM is 1.482. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.482TTM1.4820.000
TTM1.482YOY1.775-0.293
TTM1.4825Y1.508-0.026
5Y1.50810Y1.5080.000
1.3.2. Quick Ratio

Measures if AARTI DRUGS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AARTI DRUGS LTD. to the  industry mean.
  • A Quick Ratio of 0.81 means the company can pay off ₹0.81 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AARTI DRUGS LTD.:

  • The MRQ is 0.811. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.811. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.811TTM0.8110.000
TTM0.811YOY0.954-0.143
TTM0.8115Y0.834-0.023
5Y0.83410Y0.8340.000

1.4. Solvency of AARTI DRUGS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of AARTI DRUGS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AARTI DRUGS LTD. to industry mean.
  • A Debt to Asset Ratio of 0.53 means that AARTI DRUGS LTD. assets are financed with 53.1% credit (debt) and the remaining percentage (100% - 53.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AARTI DRUGS LTD.:

  • The MRQ is 0.531. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.531. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.5310.000
TTM0.531YOY0.483+0.048
TTM0.5315Y0.557-0.026
5Y0.55710Y0.5570.000
1.4.2. Debt to Equity Ratio

Measures if AARTI DRUGS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AARTI DRUGS LTD. to the  industry mean.
  • A Debt to Equity ratio of 113.1% means that company has ₹1.13 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AARTI DRUGS LTD.:

  • The MRQ is 1.131. The company is able to pay all its debts with equity. +1
  • The TTM is 1.131. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.131TTM1.1310.000
TTM1.131YOY0.933+0.197
TTM1.1315Y1.293-0.162
5Y1.29310Y1.2930.000

2. Market Valuation of AARTI DRUGS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings AARTI DRUGS LTD. generates.

  • Above 15 is considered overpriced but always compare AARTI DRUGS LTD. to the  industry mean.
  • A PE ratio of 19.37 means the investor is paying ₹19.37 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AARTI DRUGS LTD.:

  • The EOD is 18.541. Very good. +2
  • The MRQ is 19.375. Very good. +2
  • The TTM is 19.375. Very good. +2
Trends
Current periodCompared to+/- 
EOD18.541MRQ19.375-0.833
MRQ19.375TTM19.3750.000
TTM19.375YOY23.093-3.718
TTM19.3755Y35.578-16.203
5Y35.57810Y35.5780.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of AARTI DRUGS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of AARTI DRUGS LTD.:

  • The MRQ is 26.326. Seems overpriced? -1
  • The TTM is 26.326. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ26.326TTM26.3260.000
TTM26.326YOY11.645+14.682
TTM26.3265Y19.711+6.616
5Y19.71110Y19.7110.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of AARTI DRUGS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.83 means the investor is paying ₹3.83 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of AARTI DRUGS LTD.:

  • The EOD is 3.669. Neutral. Compare to industry.
  • The MRQ is 3.833. Neutral. Compare to industry.
  • The TTM is 3.833. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.669MRQ3.833-0.165
MRQ3.833TTM3.8330.000
TTM3.833YOY7.089-3.256
TTM3.8335Y7.283-3.449
5Y7.28310Y7.2830.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of AARTI DRUGS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--13.90613.9060%27.996-50%27.978-50%27.978-50%
Book Value Growth--1.1351.1350%1.400-19%1.245-9%1.245-9%
Book Value Per Share--111.912111.9120%98.005+14%84.559+32%84.559+32%
Book Value Per Share Growth--1.1421.1420%1.400-18%1.247-8%1.247-8%
Current Ratio--1.4821.4820%1.775-16%1.508-2%1.508-2%
Debt To Asset Ratio--0.5310.5310%0.483+10%0.557-5%0.557-5%
Debt To Equity Ratio--1.1311.1310%0.933+21%1.293-13%1.293-13%
Dividend Per Share--1.0271.0270%2.490-59%1.133-9%1.133-9%
Dividend Per Share Growth--0.4120.4120%3.301-88%2.203-81%2.203-81%
Eps--22.14222.1420%30.087-26%19.258+15%19.258+15%
Eps Growth--0.7360.7360%1.983-63%1.432-49%1.432-49%
Free Cash Flow Per Share---8.892-8.8920%7.159-224%6.851-230%6.851-230%
Free Cash Flow Per Share Growth---1.242-1.2420%0.329-477%0.678-283%0.678-283%
Free Cash Flow To Equity Per Share---8.892-8.8920%7.159-224%-1.075-88%-1.075-88%
Free Cash Flow To Equity Per Share Growth---1.242-1.2420%7.273-117%2.302-154%2.302-154%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.0820.0820%0.130-37%0.087-5%0.087-5%
Operating Margin----0%-0%0.056-100%0.056-100%
Operating Ratio--1.6781.6780%1.538+9%1.640+2%1.640+2%
Pb Ratio3.669-4%3.8333.8330%7.089-46%7.283-47%7.283-47%
Pe Ratio18.541-4%19.37519.3750%23.093-16%35.578-46%35.578-46%
Peg Ratio--26.32626.3260%11.645+126%19.711+34%19.711+34%
Price Per Share410.550-4%429.000429.0000%694.800-38%567.513-24%567.513-24%
Price To Total Gains Ratio27.492-4%28.72828.7280%22.791+26%25.767+11%25.767+11%
Profit Growth--0.7310.7310%1.983-63%1.430-49%1.430-49%
Quick Ratio--0.8110.8110%0.954-15%0.834-3%0.834-3%
Return On Assets--0.0930.0930%0.159-42%0.101-8%0.101-8%
Return On Equity--0.1980.1980%0.307-36%0.222-11%0.222-11%
Revenue Growth--1.1551.1550%1.193-3%1.168-1%1.168-1%
Total Gains Per Share--14.93314.9330%30.486-51%29.111-49%29.111-49%
Total Gains Per Share Growth--0.4900.4900%2.448-80%1.050-53%1.050-53%
Usd Book Value--127465072.200127465072.2000%112349159.400+13%96728509.950+32%96728509.950+32%
Usd Book Value Change Per Share--0.1710.1710%0.344-50%0.344-50%0.344-50%
Usd Book Value Per Share--1.3771.3770%1.205+14%1.040+32%1.040+32%
Usd Dividend Per Share--0.0130.0130%0.031-59%0.014-9%0.014-9%
Usd Eps--0.2720.2720%0.370-26%0.237+15%0.237+15%
Usd Free Cash Flow---10127721.600-10127721.6000%8206424.700-223%7870490.175-229%7870490.175-229%
Usd Free Cash Flow Per Share---0.109-0.1090%0.088-224%0.084-230%0.084-230%
Usd Free Cash Flow To Equity Per Share---0.109-0.1090%0.088-224%-0.013-88%-0.013-88%
Usd Price Per Share5.050-4%5.2775.2770%8.546-38%6.980-24%6.980-24%
Usd Profit--25219747.80025219747.8000%34490799.000-27%22035563.775+14%22035563.775+14%
Usd Revenue--306103433.400306103433.4000%265037915.400+15%246321494.325+24%246321494.325+24%
Usd Total Gains Per Share--0.1840.1840%0.375-51%0.358-49%0.358-49%
 EOD+3 -2MRQTTM+0 -0YOY+8 -335Y+13 -2910Y+13 -29

3.2. Fundamental Score

Let's check the fundamental score of AARTI DRUGS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.541
Price to Book Ratio (EOD)Between0-13.669
Net Profit Margin (MRQ)Greater than00.082
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.811
Current Ratio (MRQ)Greater than11.482
Debt to Asset Ratio (MRQ)Less than10.531
Debt to Equity Ratio (MRQ)Less than11.131
Return on Equity (MRQ)Greater than0.150.198
Return on Assets (MRQ)Greater than0.050.093
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of AARTI DRUGS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose413.100
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-03-312019-03-312020-03-312021-03-312022-03-31
Other Current Liabilities  171,413219,865391,278445,890837,168216,6321,053,800-1,488,800-435,000



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets22,079,584
Total Liabilities11,716,570
Total Stockholder Equity10,363,611
 As reported
Total Liabilities 11,716,570
Total Stockholder Equity+ 10,363,611
Total Assets = 22,079,584

Assets

Total Assets22,079,584
Total Current Assets13,933,728
Long-term Assets13,933,728
Total Current Assets
Cash And Cash Equivalents 216,121
Short-term Investments 126,400
Net Receivables 7,499,019
Inventory 5,259,424
Other Current Assets 825,600
Total Current Assets  (as reported)13,933,728
Total Current Assets  (calculated)13,926,564
+/- 7,164
Long-term Assets
Intangible Assets 1,533
Long-term Assets Other 284,400
Long-term Assets  (as reported)8,145,854
Long-term Assets  (calculated)285,933
+/- 7,859,921

Liabilities & Shareholders' Equity

Total Current Liabilities9,400,581
Long-term Liabilities2,315,989
Total Stockholder Equity10,363,611
Total Current Liabilities
Short Long Term Debt 3,998,404
Accounts payable 4,686,742
Other Current Liabilities -435,000
Total Current Liabilities  (as reported)9,400,581
Total Current Liabilities  (calculated)8,250,146
+/- 1,150,435
Long-term Liabilities
Long term Debt 1,384,988
Capital Lease Obligations Min Short Term Debt44,761
Long-term Liabilities Other -3
Long-term Liabilities  (as reported)2,315,989
Long-term Liabilities  (calculated)1,429,746
+/- 886,243
Total Stockholder Equity
Retained Earnings 8,787,496
Total Stockholder Equity (as reported)10,363,611
Total Stockholder Equity (calculated)8,787,496
+/- 1,576,115
Other
Capital Stock926,000
Common Stock Shares Outstanding 92,600
Net Debt 5,167,271
Net Invested Capital 15,747,003
Net Working Capital 4,533,147



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
14,628,646
15,765,011
17,660,136
22,079,584
22,079,58417,660,13615,765,01114,628,64600
   > Total Current Assets 
5,714,228
7,368,642
7,842,888
9,040,015
10,567,966
13,933,728
13,933,72810,567,9669,040,0157,842,8887,368,6425,714,228
       Cash And Cash Equivalents 
0
0
46,436
67,713
88,129
216,121
216,12188,12967,71346,43600
       Short-term Investments 
0
0
0
0
127,200
126,400
126,400127,2000000
       Net Receivables 
2,968,067
3,851,554
4,650,998
4,909,046
5,552,295
7,499,019
7,499,0195,552,2954,909,0464,650,9983,851,5542,968,067
       Inventory 
2,096,343
2,782,086
2,466,128
3,254,048
4,150,027
5,259,424
5,259,4244,150,0273,254,0482,466,1282,782,0862,096,343
       Other Current Assets 
527,811
600,995
580,992
686,267
640,700
825,600
825,600640,700686,267580,992600,995527,811
   > Long-term Assets 
0
0
6,785,759
6,770,496
7,092,170
8,145,854
8,145,8547,092,1706,770,4966,785,75900
       Property Plant Equipment 
5,892,898
6,263,047
6,547,015
6,545,264
0
0
006,545,2646,547,0156,263,0475,892,898
       Intangible Assets 
0
0
29,115
14,924
2,552
1,533
1,5332,55214,92429,11500
       Long-term Assets Other 
0
0
0
0
72,600
284,400
284,40072,6000000
> Total Liabilities 
0
0
9,194,185
9,240,138
8,526,058
11,716,570
11,716,5708,526,0589,240,1389,194,18500
   > Total Current Liabilities 
4,943,143
6,216,774
5,909,824
6,247,006
5,953,559
9,400,581
9,400,5815,953,5596,247,0065,909,8246,216,7744,943,143
       Short Long Term Debt 
0
0
2,990,040
1,990,359
1,968,223
3,998,404
3,998,4041,968,2231,990,3592,990,04000
       Accounts payable 
1,969,744
2,587,273
2,426,349
3,295,473
3,299,682
4,686,742
4,686,7423,299,6823,295,4732,426,3492,587,2731,969,744
       Other Current Liabilities 
108,580
171,413
391,278
837,168
1,053,800
-435,000
-435,0001,053,800837,168391,278171,413108,580
   > Long-term Liabilities 
0
0
3,284,361
2,993,132
2,572,499
2,315,989
2,315,9892,572,4992,993,1323,284,36100
       Capital Lease Obligations Min Short Term Debt
0
0
0
92,920
63,767
44,761
44,76163,76792,920000
       Long-term Liabilities Other 
0
0
26,938
17,448
7,960
-3
-37,96017,44826,93800
> Total Stockholder Equity
0
0
5,434,461
6,524,894
9,134,246
10,363,611
10,363,6119,134,2466,524,8945,434,46100
   Common Stock
238,571
235,821
235,821
233,000
0
0
00233,000235,821235,821238,571
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
141,644
141,692
151,579
150,450
0
0
00150,450151,579141,692141,644



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue24,886,458
Cost of Revenue-19,848,201
Gross Profit5,038,2575,038,257
 
Operating Income (+$)
Gross Profit5,038,257
Operating Expense-21,908,488
Operating Income2,977,970-16,870,231
 
Operating Expense (+$)
Research Development-
Selling General Administrative815,937
Selling And Marketing Expenses-
Operating Expense21,908,488815,937
 
Net Interest Income (+$)
Interest Income7,169
Interest Expense-207,479
Net Interest Income-231,908-200,310
 
Pretax Income (+$)
Operating Income2,977,970
Net Interest Income-231,908
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,699,5512,977,970
EBIT - interestExpense = -207,479
2,050,386
2,257,865
Interest Expense207,479
Earnings Before Interest and Taxes (ebit)-2,907,030
Earnings Before Interest and Taxes (ebitda)3,407,519
 
After tax Income (+$)
Income Before Tax2,699,551
Tax Provision-649,593
Net Income From Continuing Ops2,049,9582,049,958
Net Income2,050,386
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-231,908
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
EIMU.LSE
now

I found you a Golden Cross on the daily chart of EIMU.LSE.

EIMU.LSE Daily Candlestick Chart
CEM.MI
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEM.MI.

CEM.MI Daily Candlestick Chart
CANCDA.SW
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CANCDA.SW.

CANCDA.SW Daily Candlestick Chart
21W.F
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 21W.F.

21W.F Daily Candlestick Chart
CSPX.LSE
32 minutes ago

I found you a Golden Cross on the daily chart of CSPX.LSE.

CSPX.LSE Daily Candlestick Chart
CRL.LSE
33 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRL.LSE.

CRL.LSE Daily Candlestick Chart
CRH.LSE
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CRH.LSE.

CRH.LSE Daily Candlestick Chart
ADMIE.AT
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADMIE.AT.

ADMIE.AT Daily Candlestick Chart
DUET.NASDAQ
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DUET.NASDAQ.

DUET.NASDAQ Daily Candlestick Chart
POLY.XETRA
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of POLY.XETRA.

POLY.XETRA Daily Candlestick Chart
ENTEL.SN
1 hour ago

I found you a Golden Cross on the daily chart of ENTEL.SN.

ENTEL.SN Daily Candlestick Chart
CENCOSUD.SN
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENCOSUD.SN.

CENCOSUD.SN Daily Candlestick Chart
ANTARCHILE.SN
1 hour ago

I found you a Death Cross on the daily chart of ANTARCHILE.SN.

ANTARCHILE.SN Daily Candlestick Chart
3BBE.XETRA
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BBE.XETRA.

3BBE.XETRA Daily Candlestick Chart
FORUS.SN
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FORUS.SN.

FORUS.SN Daily Candlestick Chart
NGA1L.MI
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NGA1L.MI.

NGA1L.MI Daily Candlestick Chart
3CRE.XETRA
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3CRE.XETRA.

3CRE.XETRA Daily Candlestick Chart
GLGI.OTCQB
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GLGI.OTCQB.

GLGI.OTCQB Daily Candlestick Chart
CCMCUA.SW
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCMCUA.SW.

CCMCUA.SW Daily Candlestick Chart
AUVI.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUVI.NASDAQ.

AUVI.NASDAQ Daily Candlestick Chart
AUUD.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUUD.NASDAQ.

AUUD.NASDAQ Daily Candlestick Chart
AUPH.NASDAQ
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of AUPH.NASDAQ.

AUPH.NASDAQ Daily Candlestick Chart
WIB.STU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WIB.STU.

WIB.STU Daily Candlestick Chart
WFSTF.PINK
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WFSTF.PINK.

WFSTF.PINK Daily Candlestick Chart